Stéphane Gingras

USPTO Granted Patents = 8 (Patent Applications = 1)

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 3

Average Co-Inventor Count = 4.9

ph-index = 2

Forward Citations = 24(Granted Patents)

Location History:

Montréal, CA (2016 - 2019)
Montreal, CA (2005 - 2023)

Company Filing History:

7 out of 183

Universitéde Montreal

patents

1 out of 3,681

Bristol-myers Squibb Compnay

patents

Years Active: 2005-2025

Loading Chart...

8 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12286426 - Heterocyclic mitochondrial activity inhibitors and uses thereof (2025-04-29),

2. 11760754 - Heterocyclic mitochondrial activity inhibitors and uses thereof (2023-09-19),

3. 10647718 - Compounds and use thereof in the expansion of hematopoietic stem cells and/or hematopoietic progenitor cells (2020-05-12),

4. 10336747 - Pyrimido[4,5-B]indole derivatives and use thereof in the expansion of hematopoietic stem cells (2019-07-02),

5. 9493456 - Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulators (2016-11-15),

6. 9409906 - Pyrimido[4,5-B]indole derivatives and use thereof in the expansion of hematopoietic stem cells (2016-08-09),

7. 9018395 - Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulators (2015-04-28),

8. 6884889 - Processes for the preparation of antiviral 7-azaindole derivatives (2005-04-26),

Title: The Innovative Contributions of Stephane Gingras

Introduction

Stephane Gingras is a distinguished inventor based in Montreal, Canada, known for his significant contribution to the field of medicinal chemistry. With a focus on antiviral agents, he has made pivotal strides in developing compounds aimed at treating serious health conditions, including HIV and AIDS.

Latest Patents

Gingras holds a patent titled "Processes for the preparation of antiviral 7-azaindole derivatives." This patent includes processes and synthetic intermediates essential for creating azaindole piperazine diamide derivatives, which are recognized for their therapeutic applications in combating HIV and AIDS. This innovation demonstrates not only his technical expertise but also his commitment to addressing pressing healthcare challenges.

Career Highlights

Throughout his career, Stephane Gingras has worked with renowned institutions such as Bristol-Myers Squibb Company and Université de Montreal. His experience at these organizations has equipped him with the skills necessary to advance his research and collaborate effectively within the scientific community.

Collaborations

During his professional journey, Gingras has collaborated with notable colleagues, including Nachimuthu Soundararajan and Serge Benoit. These collaborations have likely fostered a creative environment that enhances innovation and accelerates the development of new therapeutic agents.

Conclusion

In summary, Stephane Gingras's contributions to the field of antiviral research and his innovative patents highlight the important role of inventors in addressing global health issues. His work not only exemplifies the spirit of innovation but also serves as an inspiration for emerging inventors in the biopharmaceutical sector.

This text is generated by artificial intelligence and may not be accurate.